The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

Description

The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.

Conditions

Avascular Necrosis, Osteonecrosis

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.

The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

Condition
Avascular Necrosis
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subject is at least 18 years or older with osteonecrosis of the femoral head
  • * Surgeon considers the patient appropriate for the core decompression procedure of the hip
  • * Subject provides voluntarily signature on the IRB approved Informed Consent Form
  • * Subject must be physically and mentally willing and able, in the Investigator's opinion at the time of enrollment, to be compliant with the protocol and complete the study protocol and follow ups
  • * Subject is pregnant at the time of surgery
  • * Subject is incarcerated
  • * Subject is not comfortable with speaking, reading and understanding questions and providing responses in an available language for the questionnaires provided for the study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

The Cleveland Clinic,

Nicolas Piuzzi, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2027-07